Ronald M. Evans

Ronald M. Evans

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Ronald M. Evans

Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, USA

Research Focus & Metrics

Academic Career Length

53Years (1974-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 1988 in Science
Verified
Journal Article
Closed access
PDF file
RERonald M. Evans
Ronald M. Evans
Analyses of steroid receptors are important for understanding molecular details of transcriptional control, as well as providing insight as to how an individual transacting factor contributes to cell identity and function. These studies have led to the identification of a superfamily of regulatory proteins that include receptors for thyroid hormone and the vertebrate morphogen retinoic acid. Although animals employ complex and often distinct ways to control their physiology and development, the discovery of receptor-related molecules in a wide range of species suggests that mechanisms underlying morphogenesis and homeostasis may be more ubiquitous than previously expected.

1 December 1995 in Cell
Verified
Journal Article
Closed access
DMDavid J. Mangelsdorf
David J. Mangelsdorf
CTCarl Thummel
Carl Thummel
MBMiguel Beato
Miguel Beato
PHPeter Herrlich
Peter Herrlich
GSGünther Schütz
Günther Schütz
RERonald M. Evans
Ronald M. Evans

24 January 2020 in Nature Reviews Cancer
Verified
Journal Article
Open access
PDF file
ESErik Sahai
Erik Sahai
IAIgor Astsaturov
Igor Astsaturov
ECEdna Cukierman
Edna Cukierman
DDDavid DeNardo
David DeNardo
MEMikala Egeblad
Mikala Egeblad
ZWZena Werb
Zena Werb
Cancer-associated fibroblasts (CAFs) are a key component of the tumour microenvironment with diverse functions, including matrix deposition and remodelling, extensive reciprocal signalling interactions with cancer cells and crosstalk with infiltrating leukocytes. As such, they are a potential target for optimizing therapeutic strategies against cancer. However, many challenges are present in ongoing attempts to modulate CAFs for therapeutic benefit. These include limitations in our understanding of the origin of CAFs and heterogeneity in CAF function, with it being desirable to retain some antitumorigenic functions. On the basis of a meeting of experts in the field of CAF biology, we summarize in this Consensus Statement our current knowledge and present a framework for advancing our understanding of this critical cell type within the tumour microenvironment.

1 December 1995 in Cell
Verified
Journal Article
Closed access
DMDavid J. Mangelsdorf
David J. Mangelsdorf
RERonald M. Evans
Ronald M. Evans

1 December 1995 in Cell
Verified
Journal Article
Closed access
BFBarry M. Forman
Barry M. Forman
PTPeter Tontonoz
Peter Tontonoz
JCJasmine Chen
Jasmine Chen
RBRegina P. Brun
Regina P. Brun
BSBruce M. Spiegelman
Bruce M. Spiegelman
RERonald M. Evans
Ronald M. Evans

7 May 2013 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MAMaryam Ahmadian
Maryam Ahmadian
JSJae Myoung Suh
Jae Myoung Suh
NHNasun Hah
Nasun Hah
CLChristopher Liddle
Christopher Liddle
AAAnnette R Atkins
Annette R Atkins
RERonald M Evans
Ronald M Evans